TICKER INTELLIGENCE

Vertex Pharmaceuticals Incorporated ($VRTX)

$516.44▲ 4.1% (7d)

NYSE/NASDAQ: VRTX

Washington Intelligence

1

Active Bills

0

Gov't Contracts

44

Congressional Trades

Vertex Pharmaceuticals is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 1 active Congressional signal mentioning Vertex Pharmaceuticals, including 1 bill. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.

Congressional Trades in $VRTX

44 filings

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated - Common Stock

⚠ ⚠️ PRESIDENTIAL ACTION: Presidential Memorandum signed 7/30/2026: "Presidential Determination Pursuant to Section 101 of the Defense Production Act of 1950, as Amended". This DPA action will boost investment and production in domestic critical mineral recycling and processing, likely increasing stock valuations for pure-play recovery companies and defense contractors reliant on secure rare-earth magnet supplies, while potentially raising costs for import-dependent manufacturers.

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No overlapping signals found

SELL $1,001 - $15,000 — VERTEX PHARMACEUTICALS INCORPO CMN

⚠ ⚠️ SEC 8-K FILING: WESTERN DIGITAL CORP filed 2026-05-28: "8-K: WESTERN DIGITAL CORP — Officer Departure / Appointment"

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No overlapping signals found

David J. TaylorR-OH

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated Common Stock (VRTX) [ST]

⚠ David J. Taylor bought $1,001 - $15,000 in AAPL on 2026-01-16, 6 days before HR7085, which repeals conflict mineral disclosure requirements, was placed on the Union Calendar.

Julia LetlowR-LA

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated - Common Stock

⚠ System: No suspicious timing patterns detected

BUY $1,001 - $15,000 — VERTEX PHARMACEUTICALS INCORPO CMN

SELL $1,001 - $15,000 — VERTEX PHARMACEUTICALS INCORPO CMN

⚠ System: No suspicious timing patterns detected

SELL $1,000 - $15,000 — VRTX

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Inc

BUY $1,000 - $15,000 — VRTX

⚠ System: No suspicious timing patterns detected

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No suspicious timing patterns detected

David J. TaylorR-OH

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated Common Stock

⚠ Representative David J. Taylor bought $1,001 - $15,000 in PGR (Progressive Corporation) on 2025-07-18 — 70 days before HR5608, a bill that could expand revenue opportunities for insurance companies like Progressive.

Lisa McClainR-MI

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated - Common Stock

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated - Common Stock

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated - Common Stock

⚠ System: No suspicious timing patterns detected

Rohit KhannaD-CA

BUY $1,001 - $15,000 — VERTEX PHARMACEUTICALS INCORPO CMN

⚠ System: No suspicious timing patterns detected

Byron DonaldsR-FL

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated Common Stock (VRTX) [ST]

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated Common Stock (VRTX) [ST]

⚠ Rep. Donalds sold $1,001 - $15,000 in JPM on 2025-03-20 — 12 days before the 'Sanctioning Russia Act of 2025' (HR2548) was introduced, proposing financial restrictions.

Jefferson ShreveR-IN

BUY $15,001 - $50,000 — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX)

⚠ System: No suspicious timing patterns detected

Jefferson ShreveR-IN

BUY $15,001 - $50,000 — Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) [ST]

⚠ Representative Shreve bought $15,001 - $50,000 in AMGN on February 24, 2025 — 8 days before the EPIC Act of 2025 (S832) was introduced, which proposes to extend market exclusivity for small-molecule drugs.

Rohit KhannaD-CA

BUY $1,001 - $15,000 — VERTEX PHARMACEUTICALS INCORPO CMN

⚠ System: No suspicious timing patterns detected

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No suspicious timing patterns detected

Rohit KhannaD-CA

BUY $1,001 - $15,000 — VERTEX PHARMACEUTICALS INCORPO CMN

⚠ System: No suspicious timing patterns detected

Byron DonaldsR-FL

BUY $1,001-$15,000 — Vertex Pharmaceuticals (VRTX)

BUY $1,001-$15,000 — Vertex Pharmaceuticals (VRTX)

⚠ System: No suspicious timing patterns detected

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No suspicious timing patterns detected

Thomas H Tuberville

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated - Common Stock

Tommy Tuberville

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated - Common Stock

⚠ System: No suspicious timing patterns detected

Greg StantonD-AZ

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Inc

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No suspicious timing patterns detected

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No suspicious timing patterns detected

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No suspicious timing patterns detected

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No suspicious timing patterns detected

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Inc

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No suspicious timing patterns detected

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No suspicious timing patterns detected

Rohit KhannaD-CA

SELL $1,001 - $15,000 — VERTEX PHARMACEUTICALS INCORPO CMN

SELL $1,001 - $15,000 — VERTEX PHARMACEUTICALS INCORPO CMN

⚠ System: No valid trades to analyze

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Inc

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No suspicious timing patterns detected

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Inc

SELL $15,001 - $50,000 — Vertex Pharmaceuticals Inc

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No suspicious timing patterns detected

Tommy Tuberville

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated - Common Stock

⚠ System: No suspicious timing patterns detected

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No suspicious timing patterns detected

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No suspicious timing patterns detected

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No suspicious timing patterns detected

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Inc

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Inc

⚠ System: No suspicious timing patterns detected

William R. Keating

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated

⚠ System: No suspicious timing patterns detected

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated

⚠ System: No suspicious timing patterns detected

BUY $1,001 - $15,000 — Vertex Pharma Incorporated

⚠ System: No suspicious timing patterns detected

SELL $1,001 - $15,000 — Vertex

⚠ System: No suspicious timing patterns detected

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated

BUY $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated

⚠ System: No suspicious timing patterns detected

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated

⚠ System: No suspicious timing patterns detected

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated

⚠ System: No suspicious timing patterns detected

SELL $1,001 - $15,000 — Vertex Pharmaceuticals Incorporated (NASDAQ)

⚠ System: No suspicious timing patterns detected

Related Sectors

Congressional Legislation Affecting Vertex Pharmaceuticals Incorporated ($VRTX)

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

BULLISH

HR1492 retroactively extends the Medicare price negotiation safe harbor for small-molecule drugs from 7 to 11 years, matching biologics. This shields billions in revenue for major pharma companies, particularly pure-play small-molecule firms like Vertex and large players with top-selling Part D drugs like Pfizer, Bristol-Myers Squibb, and Gilead. The bill is early-stage with 67 cosponsors and a Republican sponsor, giving it moderate momentum.

→ Vertex's cystic fibrosis drugs (Trikafta, Kalydeco, etc.) are small-molecule drugs that would face negotiation sooner under current law. Delay protects those revenues.

HR1492Feb 21, 2025

Understanding These Signals

What is a Signal?Market Sentiment Federal Contracts Full Glossary →

Get Full Access to Vertex Pharmaceuticals Incorporated ($VRTX) Signals

Daily AI-analyzed alerts for Congressional activity affecting your portfolio.

Get Started →